Division of Life Science, Hong Kong University of Science and Technology, Clear Water Bay, Hong Kong, China.
Int J Mol Sci. 2024 Sep 21;25(18):10142. doi: 10.3390/ijms251810142.
Type-A γ-aminobutyric acid (GABA) receptors are channel proteins crucial to mediating neuronal balance in the central nervous system (CNS). The structure of GABA receptors allows for multiple binding sites and is key to drug development. Yet the formation mechanism of the receptor's distinctive pentameric structure is still unknown. This study aims to investigate the role of three predominant subunits of the human GABA receptor in the formation of protein pentamers. Through purifying and refolding the protein fragments of the GABA receptor α1, β2, and γ2 subunits, the particle structures were visualised with negative staining electron microscopy (EM). To aid the analysis, AlphaFold2 was used to compare the structures. Results show that α1 and β2 subunit fragments successfully formed homo-oligomers, particularly homopentameric structures, while the predominant heteropentameric GABA receptor was also replicated through the combination of the three subunits. However, homopentameric structures were not observed with the γ2 subunit proteins. A comparison of the AlphaFold2 predictions and the previously obtained cryo-EM structures presents new insights into the subunits' modular structure and polymerization status. By performing experimental and computational studies, a deeper understanding of the complex structure of GABA receptors is provided. Hopefully, this study can pave the way to developing novel therapeutics for neuropsychiatric diseases.
A型 γ-氨基丁酸(GABA)受体是中枢神经系统(CNS)中介导神经元平衡的关键通道蛋白。GABA 受体的结构允许多个结合位点,是药物开发的关键。然而,受体独特的五聚体结构的形成机制仍然未知。本研究旨在探讨人类 GABA 受体的三个主要亚基在蛋白五聚体形成中的作用。通过纯化和重折叠 GABA 受体α1、β2 和 γ2 亚基的蛋白片段,使用负染色电子显微镜(EM)可视化颗粒结构。为了辅助分析,使用 AlphaFold2 来比较结构。结果表明,α1 和 β2 亚基片段成功形成同型寡聚体,特别是同五聚体结构,而通过三个亚基的组合也复制了主要的异五聚体 GABA 受体。然而,γ2 亚基蛋白没有观察到同五聚体结构。AlphaFold2 预测和先前获得的冷冻电镜结构的比较为亚基的模块化结构和聚合状态提供了新的见解。通过进行实验和计算研究,对 GABA 受体的复杂结构有了更深入的了解。希望这项研究能够为神经精神疾病的新型治疗方法铺平道路。